Metabolic Syndrome – A New Definition and Management Guidelines: A Joint Position Paper by Various Polish Medical Societies

August 2022 in “ Archives of Medical Science ”

Piotr Dobrowolski, Aleksander Prejbisz, Alina Kurylowicz, Alicja Baska, Paweł Burchardt, Krzysztof Chlebus, Grzegorz Dzida, Piotr Jankowski, Jerzy Jaroszewicz, Paweł Jaworski, Karol Kamiński, Agnieszka Kapłon-Cieślicka, Marek Klocek, Michał Kukla, Artur Mamcarz, Agnieszka Mastalerz-Migas, Krzysztof Narkiewicz, Lucyna Ostrowska, Daniel Śliż, Wiesław Tarnowski, Jacek Wolf, Mariusz Wyleżoł, Tomasz Zdrojewski, Maciej Banach, Andrzej Januszewicz, Paweł Bogdański

Studysummary This publication discusses the 2021 ESC Guidelines for the prevention of cardiovascular disease in clinical practice and reports no new results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on archivesofmedicalscience.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

815 citations , April 2010 in “The Journal of Clinical Endocrinology & Metabolism”

This review examines the relationship between polycystic ovary syndrome and cardiovascular disease risk, but reports no new clinical findings; the panel calls for guidelines to prevent CVD in this population.